The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line

Gastroenterology

Volumn 118, Issue 4, 2000, Pages 724-734

  Inan, Mehmet Sait ^a   Rasoulpour, Reza J ^a   Yin, Lei ^a   Hubbard, Andrea K ^a   Rosenberg, Daniel W ^a   Giardina, Charles ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; PHORBOL ESTER; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DEACETYLATION; DNA BINDING; ENTERITIS; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034062353     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70142-9     Document Type: Article

References (70)

1. R Sen, and D. Baltimore Multiple nuclear factors interact with the immunoglobin enhancer sequences Cell 46 1986 705 716
2. PA Baeuerle, and T. Henkel Function and activation of NF-κB in the immune system Annu Rev Immunol 14 1994 649 681
3. M Grilli, JJ-S Chiu, and MJ. Lenardo NF-κB and Rel: participants in a multiform transcriptional regulatory system Int Rev Cytol 143 1993 1 62
4. C-Y Wang, MW Mayo, and ASB Jr TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB Science 274 1996 784 787
5. DJ VanAntwerp, SJ Martin, T Kafri, DR Green, and IM. Verma Suppression of TNF-induced apoptosis by NF-κB Science 274 1996 787 789
6. AA Beg, and D. Baltimore An essential role for NF-κB in preventing TNF-induced cell death Science 274 1996 782 784
7. AA Beg, WC Sha, RT Bronson, S Ghosh, and D. Baltimore Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB Nature 376 1995 167 170
8. RE Bellas, MJ Fitzgerald, N Fausto, and GE. Sonenshein Inhibition of NF-κB activity induces apoptosis in murine hepatocytes Am J Pathol 151 1997 891 896
9. M Wu, H Lee, RE Bellas, SL Schauer, M Arsura, D Katz, MJ FitzGerald, TL Rothstein, DH Sherr, and GE. Sonenshein Inhibition of NF-κB/Rel induces apoptosis of murine B cells EMBO J 15 1996 4682 4690
10. G Taglialatela, R Robinson, and JR. Perez-Polo Inhibition of nuclear factor kappa B (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells J Neurosci Res 47 1997 155 162
11. AA Beg, and D. Baltimore An essential role for NF-κB in preventing TNF-induced cell death Science 274 1996 782 784
12. Y Iimuro, T Nishiura, C Hellerbrand, KE Behrns, R Schoonhoven, JW Grisham, and DA. Brenner NF-κB prevents apoptosis and liver dysfunction during liver regeneration J Clin Invest 101 1998 802 811
13. VR Baichwal, and PA. Baeuerle Apoptosis: activate NF-κB or die? Curr Biol 7 1997 R94 R96
14. K-I Lin, S-H Lee, R Narayanan, JM Baraban, JM Hardwick, and RR. Ratan Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B J Cell Biol 131 1995 1149 1161
15. D Thanos, and T. Maniatis NF-κB: a lesson in family values Cell 80 1995 529
16. TD Gilmore, and PJ. Morin The IκB protein: members of a multifunctional family Trends Genet 9 1993 427 433
17. JA DiDonato, M Hayakawa, DM Rothwarf, E Zandi, and M. Karin A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB Nature 388 1997 548 554
18. FS Lee, J Hagler, ZJ Chen, and T. Maniatis Activation of the IkB kinase complex by MEKK1, a kinase of the JNK pathway Cell 88 1997 213 222
19. F Mercurio, H Zhu, BW Murray, A Shevchenko, BL Bennett, J Li, DB Young, M Barbosa, M Mann, A Manning, and A. Rao IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 278 1997 860 866
20. E Zandi, DM Rothwarf, M Delhase, M Hayakawa, and M. Karin The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 91 1997 243 252
21. AA Beg, TS Finco, PV Nantermet, and JAS. Baldwin Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB: mechanism for NF-κB activation Mol Cell Biol 13 1993 3301 3310
22. T Henkel, T Machledidt, I Alkalay, M Kronke, Y Ben-Neriah, and PA. Baeuerle Rapid proteolysis of IκB- is necessary for activation of transcription factor NF-κB Nature 365 1993 182 185
23. DC Scherer, JA Brockman, Z Chen, T Maniatis, and DW. Ballard Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination Proc Natl Acad Sci USA 92 1995 11259 11263
24. VJ Palombella, OJ Rando, AL Goldberg, and T. Maniatis The ubiquitin-proteasome pathway is required for processing of NF-κB1 precursor protein and the activation of NF-κB Cell 78 1994 773 785
25. C Sears, J Olesen, D Rubin, D Finley, and T. Maniatis NF-kappa B p105 processing via the ubiquitin-proteasome pathway J Biol Chem 273 1998 1409 1419
26. H Ishikawa, R-P Ryseck, and R. Bravo Characterization of ES cells deficient for the p105 precursor (NF-κB1): role of p50 NLS Oncogene 13 1996 255 263
27. D Kvale, and P. Brandtzaeg Constitutive and cytokine induced expression of HLA molecules, secretory component, and intracellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29 Gut 36 1995 737 742
28. RD McCall, S Haskill, EM Zimmermann, PK Lund, RC Thompson, and RB. Sartor Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats Gastroenterology 106 1994 960 972
29. C Jobin, S Haskill, L Mayer, A Panja, and RB. Sartor Evidence for altered IκB degradation in human colonic epithelial cells J Immunol 158 1997 226 234
30. A Panja, A Barone, and L. Mayer Stimulation of lamina propria lymphocytes by intestinal epithelial cells J Exp Med 179 1994 943 950
31. A Panja, E Siden, and L. Mayer Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells J Clin Immunol 100 1995 928
32. E Ardite, J Panes, M Miranda, A Salas, JI Elizalde, M Sans, Y Arce, JM Bordes, JC Fernandez-Checa, and JM. Pique Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease Br J Pharmacol 124 1998 431 433
33. G Rogler, K Brand, D Vogl, S Page, R Hofmeister, T Andus, R Knuechel, PA Baeuerle, J Scholmerich, and V. Gross Nuclear factor κB is activated in macrophages and epithelial cells of inflamed mucosa Gastroenterology 115 1998 357 369
34. IG DePlaen, X-D Tan, H Chang, X-W Qu, Q-P Liu, and W. Hsueh Intestinal NF-κB is activated, mainly p50 homodimers, by platelet-activating factor Biochim Biophys Acta 1392 1998 185 192
35. A McIntyre, PR Gibson, and GP. Young Butyrate production from dietary fiber and protection from large bowel cancer in a rat model Gut 34 1993 386 391
36. B Singh, AP Halestrap, and C. Paraskeva Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources Carcinogenesis 18 1997 1265 1270
37. A Hague, B Singh, and C. Paraskeva Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate Gastroenterology 112 1997 1036 1040
38. JA Barnard, and G. Warwick Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells Cell Growth Differ 4 1993 495 501
39. RA Hodin, S Meng, S Archer, and R. Tang Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells Cell Growth Differ 7 1996 647 653
40. P Gibson, and O. Rosella Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease Gut 37 1995 536 543
41. JM Harig, KH Soergel, RA Komorowski, and CM. Wood Treatment of diversion colitis with short chain fatty acid irrigation N Engl J Med 320 1989 23 28
42. MAS Chapman, MF Grahn, MA Boyle, M Hutton, J Rogers, and NS. Williams Butyrate oxidation is impaired in colonic mucosa of sufferers of quiescent ulcerative colitis Gut 35 1994 73 76
43. MR Clausen, PB Mortensen, K Holtug, I Nordgaard, H Hove, and PB. Jessen Kinetic studies on colonocyte metabolism of short-chain fatty acids and glucose in patients with ulcerative colitis (abstr) Gastroenterology 106 1994 A666
44. E Kopp, and S. Ghosh Inhibition of NF-κB by sodium salicylate and aspirin Science 265 1994 956 959
45. C Brostjan, J Anrather, V Csizmadia, D Stroka, M Soares, FH Bach, and H. Winkler Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκB synthesis J Biol Chem 271 1996 19612 19616
46. C Giardina, and MS. Inan Nonsteroidal antiinflammatory drugs, short chain fatty acids and reactive oxygen metabolism in human colorectal cancer cells Biochim Biophys Acta 1401 1998 277 288
47. S Schutze, K Potthoff, T Machleidt, D Berkovic, K Weigmann, and M. Kronke TNF activates NF-κB by phosphatidyl choline-specific phospholipase C-induced "acidic" sphingomyelin breakdown Cell 71 1992 765 776
48. FR Homaidan, L Zhao, V Donavan, NL Shinowara, and R. Burakoff Separation of pure populations of epithelial cells from rabbit distal colon Anal Biochem 224 1995 134 139
49. M Tsujii, and RN. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
50. ASJ. Baldwin The NF-κB and IκB proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 681
51. C Kunsch, and CA. Rosen NF-κB subunit-specific regulation of the interleukin-8 promoter Mol Cell Biol 13 1993 6137 6146
52. H Ishikawa, E Claudio, D Dambach, C Raventos-Suarez, C Ryan, and R. Bravo Chronic inflammation and suceptibility to bacterial infections in mice lacking the polypeptide p105 precursor (NF-κB1) but expressing p50 J Exp Med 187 1998 985 996
53. O Benard, and KA. Balasubramanian Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells Mol Cell Biochem 170 1997 109 114
54. L Gamet, D Daviaud, C Denis-Pouxviel, C Remesy, and JC. Murat Effects of short chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29 Int J Cancer 52 1992 286 289
55. LS Cousens, D Gallwitz, and BM. Alberts Different accessibilities in chromatin to histone deacetylase J Biol Chem 254 1979 1716 1723
56. KM Herold, and PG. Rothberg Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells Oncogene 3 1988 423 428
57. S Siavoshian, HM Blottiere, C Cherbut, and J-P. Galmiche Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells Biochem Biophys Res Commun 232 1997 169 172
58. M Yoshida, M Kijima, M Akita, and T. Beppu Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A J Biol Chem 265 1990 17174 17179
59. M Yoshida, S Horinouchi, and T. Beppu Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function Bioessays 17 1995 423 430
60. W Gu, and RG. Roeder Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 1997 595 606
61. J Boyes, P Byfield, Y Nakatani, and V. Ogrzko Regulation of GATA-1 by acetylation Nature 396 1998 594 598
62. JH Kim, S Meng, A Shei, and RA. Hodin A novel Sp1-related cis element involved in intestinal alkaline phosphatase gene transcription Am J Physiol 276 1999 G800 G807
63. W Dippold, B Wittig, W Schwaeble, W Mayet, and KHMZ Buschenfelde Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells Gut 34 1993 1593 1597
64. L Mazzucchelli, C Hauser, K Zgraggen, H Wagner, M Hess, JA Laissue, and C. Mueller Expression of interleukin-8 gene in inflammatory bowel disease is related to histological grade active inflammation Am J Pathol 144 1994 997 1007
65. A Woywodt, D Ludwig, P Neustock, A Kruse, K Schwarting, G Jantschek, H Kirchner, and EF. Stange Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease Eur J Gastroenterol Hepatol 11 1999 267 276
66. FJ Baert, GR D'Haens, M Peeters, MI Hiele, TF Schaible, D Shealy, K Geboes, and PJ. Rutgeert Tumor necrosis factor alpha antibody (inflixmab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis Gastroenterology 116 1999 22 28
67. M Noguchi, N Hiwatashi, Z Liu, and T. Toyota Secretion imbalance between tumor necrosis factor and its inhibitor in inflammatory bowel disease Gut 43 1998 203 209
68. C Wahl, S Liptay, G Adler, and RM. Schmid Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B J Clin Invest 101 1998 1163 1174
69. GC Kaiser, F Yan, and DB. Polk Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappa B activation in mouse colonocytes Gastroenterology 116 1999 602 609
70. LJ Egan, DC Mays, CJ Huntoon, MP Bell, MG Pike, WJ Sandborn, JJ Lipsky, and DJ. McKean Inhibition of interleukin-1-stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity J Biol Chem 274 1999 26448 26453